Drug Pipeline

SKY-0515 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
3
Phase 3
1
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-05 NCT07378644
Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants…		 Trial sites expanded: 4 -> 8 locations
Active Studies by Phase
Phase 2/3
3
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07378644 Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants… Huntington Disease Recruiting
NCT06873334 Study of SKY-0515 for Safety, Efficacy, and Pharmacodynamics in Participants With… Huntington Disease Active, Not Recruiting
NCT07537075 An Extension of SKY-0515 in Participants With Huntington's Disease Huntington's Disease (HD) Enrolling by Invitation
Sponsors Running SKY-0515 Trials
Skyhawk Therapeutics, Inc. (3)
Disease Areas
Huntington's Disease (3)
Get alerts when SKY-0515 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free